HSG, formerly known as Sequoia Capital China, is a global venture capital and private equity firm, managing over USD 55 billion across various funds. Established in 2005, HSG invests in technology, healthcare, and consumer sectors, with a focus on seed, venture, growth, buyout, and infrastructure stages. The firm has backed over 1,500 companies, with more than 160 listed on public exchanges and over 140 achieving unicorn status. HSG operates globally, with offices in Hong Kong, Shanghai, Beijing, Shenzhen, London, Tokyo, and Singapore, providing extensive resources and industry expertise to its portfolio companies.
2800 Sand Hill Road, Suite 101 Menlo Park, California 94025, USA
Room 3606 China Central Place Tower 3 77 Jianguo Road Chaoyang District Beijing 100025, China
6th Floor, East Wing, Block B, Divyasree Technopolis, Off HAL Airport Road, Yemalur, Kadubeesanahalli, Bengaluru, Karnataka 560037, India
Rohit Agarwal
Managing Director
Wang Chenyu
Vice President
Sakshi Chopra
Managing Director
Raghavv Garg
Analyst
Amit Jain
Managing Director
Pushpak Kedia
Vice President
Sunint Khurana
Analyst
Cherry Lu
Partner
Ishaan Mittal
Managing Director
Saksham Mittal
Analyst
Abhishek Mohan
Principal
Javier Ng
Associate
Enita Pu
Partner
Wendy Qian
Analyst
Haim Sadger
Partner
Harshjit Sethi
Managing Director
Yoav Shaked
Partner
Johan Surani
Vice President
Vedant Trivedi
Associate
Aradhita Tuli
Investment Analyst
Pavel Vyhnalek
Operating Partner
Fu Xin
Partner
Past deals in Shanghai
Naen Auto
Venture Round in 2024
Shanghai NAEN Auto Technology Co., Ltd. specializes in automotive electronics, focusing on the development and manufacturing of advanced products for automobile manufacturers. The company's offerings include a range of systems such as passive entry passive start (PEPS), electronic steering column locks (ESCL), smart air conditioning (AC), body control modules (BCM), heads-up display (HUD) systems, domain control units (DCU), capacitive sensors (CS), and kick sensors (KS). By providing these innovative solutions, NAEN Auto supports the production of intelligent vehicles, enhancing functionality and user experience in modern automobiles.
RD Technologies
Series A in 2024
RD Technologies Group (RD Technologies) is a financial platform that bridges the Web2 and Web3 worlds. RD Technologies' secure and innovative solutions include: • RD Wallet: RD Wallet Technologies Limited (RD Wallet) is a licensed Stored Value Facility in Hong Kong (licence number: SVF0016). It enables global businesses to open multi-currency fiat accounts on mobile anytime, anywhere. • HKDR Stablecoin (HKDR): HKDR Stablecoin (HKDR) is a compliant and transparent Hong Kong Dollar stablecoin 1:1 backed by the Hong Kong dollar, with high-quality and highly liquid assets safekept in segregated custody accounts with licensed financial institutions. Details of the reserves will be available to the public through regular independent attestation reports. In July 2024, RD InnoTech Limited, the issuer of HKDR, was among the first batch of entities to be admitted to the stablecoin issuer sandbox by the Hong Kong Monetary Authority. • HKDR Stablecoin (HKDR): HKDR Stablecoin (HKDR) is a compliant and transparent Hong Kong Dollar stablecoin 1:1 backed by the Hong Kong dollar, with high-quality and highly liquid assets safekept in segregated custody accounts with licensed financial institutions. Details of the reserves will be available to the public through regular independent attestation reports. In July 2024, RD InnoTech Limited, the issuer of HKDR, was among the first batch of entities to be admitted to the stablecoin issuer sandbox by the Hong Kong Monetary Authority.
Xiaohongshu
Secondary Market in 2024
Xiaohongshu, founded in 2013 and based in Shanghai, China, is a lifestyle sharing platform that allows users to share experiences through text, images, and videos. Initially aimed at assisting overseas travelers with shopping, it has transformed into a vibrant community focused on various lifestyle areas, including cosmetics, fashion, food, travel, entertainment, reading, fitness, and childcare. The platform serves as a social e-commerce space where users can post their favorite products, share shopping experiences, and discover global merchandise, particularly in luxury and beauty sectors. By fostering user-generated content, Xiaohongshu encourages a collaborative environment for lifestyle enthusiasts to exchange insights and recommendations.
Xiaohongshu
Secondary Market in 2023
Xiaohongshu, founded in 2013 and based in Shanghai, China, is a lifestyle sharing platform that allows users to share experiences through text, images, and videos. Initially aimed at assisting overseas travelers with shopping, it has transformed into a vibrant community focused on various lifestyle areas, including cosmetics, fashion, food, travel, entertainment, reading, fitness, and childcare. The platform serves as a social e-commerce space where users can post their favorite products, share shopping experiences, and discover global merchandise, particularly in luxury and beauty sectors. By fostering user-generated content, Xiaohongshu encourages a collaborative environment for lifestyle enthusiasts to exchange insights and recommendations.
Neurophth Therapeutics
Series C in 2023
Wuhan Neurophth Biotechnology Co., Ltd. is a pioneering ophthalmology gene drug research and development company based in Wuhan, China, established in 2008. It focuses on gene therapies for ocular genetic diseases, with a particular emphasis on Leber hereditary optic neuropathy (LHON), a condition caused by genetic mutations. Neurophth has made significant advancements in the field, completing the world's first clinical study of gene therapy for LHON in 2011, which involved nine patients and has since observed their progress over seven years. The company aims to develop effective treatments for various ophthalmic disorders, including degenerative optic nerve injuries and vascular retinopathy, thereby providing physicians with innovative therapeutic options for patients suffering from these conditions.
Micro Connect
Series C in 2023
Micro Connect is a financial market platform that specializes in connecting global capital with China's micro and small businesses. The company focuses on enhancing liquidity in small business investments by providing professional investors with a new alternative to traditional impact investing. Micro Connect introduces Daily Revenue Obligations (DROs), an innovative asset class that allows investors to gain direct and diversified exposure to the daily cash flows of numerous retail establishments within China's dynamic consumer market. By facilitating access to capital for business owners, Micro Connect aims to create a more affordable financial ecosystem, while also offering structured product solutions and operating a licensed exchange.
SUNRATE
Series D in 2023
SUNRATE is a global payment and treasury management platform established in 2016, designed to support businesses in scaling their operations both locally and internationally. With its headquarters in Singapore and additional offices in Hong Kong, Jakarta, London, and Shanghai, SUNRATE serves clients in over 190 countries and regions. The platform provides a variety of services, including international payments, virtual corporate cards, global collections, and comprehensive treasury management solutions. By partnering with leading financial institutions and leveraging advanced technology, SUNRATE facilitates smoother international trade for small and medium-sized enterprises, helping them navigate the complexities of global commerce.
SHEIN
Venture Round in 2023
SHEIN is an online marketplace that specializes in women's apparel, offering a wide range of fashion items including clothing, shoes, jewelry, and accessories. Founded in 2008 and headquartered in Jiangsu, China, SHEIN operates as an international B2C fast fashion e-commerce platform, serving customers in over 220 countries and regions. The company utilizes on-demand manufacturing technologies to link suppliers with an agile supply chain, effectively reducing inventory waste and allowing for the delivery of a diverse array of affordable products. By focusing on accessibility and affordability, SHEIN aims to make fashion accessible to a global audience.
DeepLang AI
Venture Round in 2023
DeepLang AI focuses on creating an advanced Chinese information processing engine powered by its proprietary large-scale model. The company specializes in developing intelligent text information processing solutions tailored for workers and organizations in China. Utilizing artificial intelligence and natural language processing technologies, DeepLang AI's engine offers a range of functionalities, including AI-generated content text generation, information extraction and aggregation, and semantic retrieval. These capabilities are designed to enhance productivity and improve efficiency in managing textual data within information-intensive environments.
Phabuilder
Series A in 2023
PhaBuilder is a technology company specializing in synthetic biology, particularly in the transformation and engineering of halophilic microbes. Founded in February 2021 by Professor Guoqiang Chen, the company employs advanced methodologies to develop high-value products such as biodegradable polyhydroxyalkanoates (PHA), ectoine for pharmaceuticals, and cadaverine for nylon production. PhaBuilder is currently constructing two PHA production facilities, one in Beijing and another in Yichang, with plans to establish three to five large-scale production sites across China within five years. The company has successfully completed two rounds of financing, securing approximately 300 million yuan from notable investors. PhaBuilder aims to integrate synthetic biotechnology into various aspects of daily life and enhance the intelligent biological manufacturing sector, aspiring to fulfill its mission of utilizing microbes to foster a sustainable and eco-friendly future.
Locad
Series A in 2023
Locad is a logistics provider that supports e-commerce brands in the Asia-Pacific region by offering a cloud-based supply chain solution. Its technology platform enables seamless inventory synchronization across various online sales channels and facilitates end-to-end order fulfillment through a network of warehouses and carriers in countries such as Singapore, the Philippines, Thailand, Hong Kong, and Australia. By leveraging a geographically distributed warehousing infrastructure, Locad allows brands to store products closer to their customers, resulting in quicker delivery times and reduced shipping costs. The platform provides easy integration with sales channels and offers on-demand capacity, making it adaptable to the varied needs of clients. With hundreds of brands utilizing its services, Locad aims to enhance shipping efficiency, lower expenses, and support significant business growth.
Haawking
Series A in 2022
HAAWKING is a developer and manufacturer of digital signal processors and microprocessors, specializing in applications for industrial control, motor drives, digital power supplies, photovoltaic systems, energy storage, and consumer electronics. Based in China, the company emphasizes research and development in its product offerings, which also include machine vision chips tailored for use in industrial robots and intelligent applications such as augmented reality and autonomous driving. HAAWKING aims to enhance computing efficiency and reduce costs for its clients across various sectors. Customers can reach out to the company through email and phone for inquiries and support.
Zhonghai Chuneng Technology Beijing
Seed Round in 2022
Zhonghai Chuneng Technology Beijing develops energy storage technology and the production, and sales of energy storage equipment.
Cataya Bio
Series A in 2022
Cataya Bio (Shanghai) Co., Ltd. is focused on developing synthetic biological products for diverse industries through its advanced engineering biology platform and biomanufacturing capabilities. The company engineers microbes and creates clean fermentation processes to produce high-purity products sustainably and cost-effectively. By leveraging synthetic biology technology, Cataya Bio enables clients to obtain natural and sustainable raw materials, contributing to a shift away from petroleum-based resources. The company's efforts address critical global challenges such as environmental preservation, carbon emissions, and climate change.
Insight Lifetech
Series D in 2022
Insight Lifetech is a medical technology company focused on creating innovative solutions for the diagnosis and treatment of cardiovascular diseases. It has developed a synergistic platform that integrates research and development, manufacturing, and commercialization, which enhances collaboration, accelerates product development, and promotes cost efficiency. The company is notable for creating the first and only domestic fractional flow reserve (FFR) system in China that has received approval from the National Medical Products Administration (NMPA). By manufacturing high-quality medical devices that feature reliable precision diagnostics and therapeutic capabilities, Insight Lifetech aims to empower physicians to improve patient outcomes and save lives.
XellSmart
Series A in 2022
XellSmart is a company based in Minhang District, Shanghai, China, focused on developing stem cell treatment solutions for various degenerative diseases that currently lack effective clinical treatments. The firm aims to enhance disease treatment and facilitate drug discovery through innovative stem cell therapies. XellSmart is dedicated to offering large-scale and cost-effective stem cell treatment, replacement, and transplantation options, specifically targeting major conditions like Parkinson's disease. By advancing these solutions, XellSmart seeks to provide patients with viable clinical alternatives to improve their health outcomes.
Mech-Mind Robotics
Series C in 2022
Mech-Mind Robotics Technologies, founded in 2016 and based in Beijing, China, specializes in manufacturing smart cameras and developing AI-powered software for the logistics industry. The company produces a range of cameras, including the Mech-Eye Smart Camera, designed for tasks such as object recognition, depalletizing, assembly, sorting, and locating. Mech-Mind's technology integrates 3D vision with artificial intelligence, enabling robots to recognize objects of various shapes and sizes. With over 10,000 cameras deployed across more than 50 countries, Mech-Mind Robotics supports partners and system integrators in addressing complex automation challenges, including logistics parcel picking and related operations. The company also maintains an office in Munich, Germany, and a sales office in Shanghai, China.
HAI ROBOTICS
Series D in 2022
HAI ROBOTICS, founded in 2016 and based in Shenzhen, China, specializes in autonomous case-handling robotic systems for warehouse automation. The company offers a variety of intelligent solutions, including a goods-to-person system, smart in-plant logistics solutions for manufacturing, and multi-tier steel platforms for diverse applications. As a pioneer in the field, HAI ROBOTICS launched its first autonomous case-handling robot, HAIPICK, in 2015, and has since focused on research and development, securing numerous patents. The HAIPICK system significantly enhances warehouse efficiency, reportedly increasing operational productivity by three to four times and boosting storage density by 80% to 130%. HAI ROBOTICS caters to a broad range of clients, including major logistics and supply chain companies, and is committed to delivering flexible and customizable automation solutions to optimize warehouse operations.
NuProbe
Series B in 2022
NuProbe, Inc. is a genomics and molecular diagnostics company that focuses on noninvasive nucleic acid profiling and diagnostics. Founded in 2016 and headquartered in Cambridge, Massachusetts, with an additional office in Shanghai, China, NuProbe has developed a platform that utilizes genetic toehold probes for quantitative PCR mutation detection. The company's innovative technology offers a Sample-In Answer-Out (SIAO) solution, which seamlessly integrates cell-free DNA extraction, qPCR analysis, sequencing, and bioinformatic interpretation. This precision diagnostic technology is designed to facilitate the early detection of cancer and infectious diseases by accurately capturing disease signatures with high sensitivity and multiplexing capability, allowing healthcare professionals to initiate timely interventions for patients.
Supreium Technology
Series A in 2022
Supreium specializes in the development of computer-aided engineering (CAE) simulation software solutions tailored for intelligent manufacturing. Founded in 2016 and headquartered in Beijing, China, the company offers a software as a service (SaaS) platform that includes various services such as mold design, injection process analysis, and thermal balance assessments. Its offerings also encompass automatic defect detection through image scanning and process consulting services. Serving diverse sectors including medical treatment, marine water conservancy, communications, and industrial markets, Supreium is committed to advancing high-performance digital solutions through its innovative algorithms and cloud-native simulation technologies. The company is recognized for its focus on intelligent industrial design applications and is positioned at the forefront of CAE technology development.
EPiCMEMS
Series A in 2022
EPiCMEMS, a local chip company based in Xiamen, specializes in the development of RF front-end solutions, focusing on 4G+ and 5G RF filters and chips. The company aims to advance the domestic chip industry by producing high-speed, high-quality 5G chips tailored for mobile devices and the Internet of Things (IoT). With operational facilities in Xiamen and Zhangjiang, along with sales and customer support centers in Shenzhen, Xi'an, and Beijing, EPiCMEMS is committed to enhancing connectivity and stability for users across the mobile and IoT sectors.
KAWO 科握
Series A in 2022
KAWO Technology LLC, founded in 2013 and based in Shanghai, specializes in providing social media solutions for international brands seeking to engage with Chinese audiences. The company develops an application that facilitates the creation and sharing of short-form videos and GIFs, specifically tailored for platforms such as Weibo and WeChat. KAWO's innovative tools enable brands to maintain authenticity and consistency across their social media channels while integrating Western platforms like Facebook and Twitter with their Chinese counterparts. By offering data insights and promoting transparency, KAWO enhances operational efficiency for global teams, allowing them to navigate the rapidly evolving Chinese social media landscape effectively.
SHEIN
Series F in 2022
SHEIN is an online marketplace that specializes in women's apparel, offering a wide range of fashion items including clothing, shoes, jewelry, and accessories. Founded in 2008 and headquartered in Jiangsu, China, SHEIN operates as an international B2C fast fashion e-commerce platform, serving customers in over 220 countries and regions. The company utilizes on-demand manufacturing technologies to link suppliers with an agile supply chain, effectively reducing inventory waste and allowing for the delivery of a diverse array of affordable products. By focusing on accessibility and affordability, SHEIN aims to make fashion accessible to a global audience.
Micro Connect
Series B in 2022
Micro Connect is a financial market platform that specializes in connecting global capital with China's micro and small businesses. The company focuses on enhancing liquidity in small business investments by providing professional investors with a new alternative to traditional impact investing. Micro Connect introduces Daily Revenue Obligations (DROs), an innovative asset class that allows investors to gain direct and diversified exposure to the daily cash flows of numerous retail establishments within China's dynamic consumer market. By facilitating access to capital for business owners, Micro Connect aims to create a more affordable financial ecosystem, while also offering structured product solutions and operating a licensed exchange.
XVERSE
Series A in 2022
XVERSE is a technology company platform that develops 3D user-generated content. It aims to become one of the operating systems (OS) of the true Internet and one of the important content providers. The company is located in Shenzhen, China.
Inceptio Technology
Series B in 2022
Inceptio Technology, founded in 2018 and based in Shanghai, China, specializes in the development of autonomous driving trucks aimed at transforming line-haul logistics. The company offers a nationwide freight network and provides a Transportation-As-A-Service model that enhances the security, efficiency, and cost-effectiveness of logistics operations. Utilizing advanced technologies such as artificial intelligence, new energy solutions, and logistics big data, Inceptio's heavy-duty trucks deliver innovative and safe logistics solutions tailored for logistics companies. Additionally, the company has established research and development centers in both Shanghai and Silicon Valley to further its technological advancements.
WeShine Network
Series B in 2022
WeShine is a marketing and service platform that specializes in corporate account management solutions, primarily utilizing WeChat to enhance customer acquisition for businesses. Established in 2015 and headquartered in Nanjing, China, WeShine has successfully served over 150,000 businesses, with more than 30,000 of these being paid enterprise users. The platform focuses on integrated marketing and media services that leverage social media to enable mobile interaction and digital content sharing, helping clients to expand their customer base and improve marketing accuracy. With a global network of over 600 channel partners, WeShine operates offices in several major Chinese cities, including Guangzhou, Shenzhen, Beijing, Shanghai, Wuxi, and Wuhan.
Amber Group
Series B in 2022
Amber Group Limited is a cryptocurrency financial services provider based in Hong Kong, founded in 2015. The company specializes in facilitating the buying and selling of cryptocurrency products and offers a range of services, including yield enhancement, collateralized lending, decentralized finance, execution services, and electronic market making. With a global presence that includes operations in Taipei, Seoul, and Vancouver, Amber Group serves over 200 institutional clients and has traded more than $200 billion across multiple electronic exchanges. It aims to optimize investment flexibility and maximize returns for its clients by leveraging advanced technology and quantitative research. Amber Group is dedicated to delivering a streamlined cryptocurrency finance experience, helping clients build and protect their wealth over the long term.
Modalku
Series C in 2022
Modalku is an online marketplace based in Jakarta, Indonesia for small businesses to acquire loans and for lenders to fund small business loans to earn compelling returns. Its technology-based approach enables borrowers to receive loans for the first time or at lower than market rates, while lenders will earn returns well above that of bank deposits, traditional fixed income products, and life insurance investment-linked products. This marketplace lending model is proven in countries such as USA, UK, China & Singapore.
SceneRay
Series D in 2022
SceneRay Co. Ltd, based in Singapore Industrial Park, Suzhou, China, specializes in the design, development, and distribution of neuromodulation devices, particularly focusing on brain pacemakers. The company’s core team comprises experts with extensive experience in neuromodulation device development, manufacturing, and marketing, both in China and internationally. SceneRay's product offerings include a dual-channel implantable pulse generator kit designed for deep brain stimulation, which provides therapeutic electric stimulation to address issues related to brain damage. Committed to innovation, SceneRay holds numerous patents and strives to deliver high-quality, effective treatments for patients.
Qianglian Zhichuang
Series C in 2022
the first high-tech company in China to focus on the treatment of cerebrovascular disease, it has more than four years of product research and development, leading China's cerebrovascular disease intelligence in an all-around way. vertical field of diagnosis and treatment. It has become a well-known brain stroke intelligence diagnosis and treatment platform in China.
Tongxin Medical Equipment
Series D in 2022
Tongxin makes magnetically-suspended artificial blood pumps which are designed to replace the human heart. They are undergoing clinical trials in China after being fast-tracked through the approval process by the National Medical Products Administration, state-run Xinhua News Agency
Phabuilder
Venture Round in 2022
PhaBuilder is a technology company specializing in synthetic biology, particularly in the transformation and engineering of halophilic microbes. Founded in February 2021 by Professor Guoqiang Chen, the company employs advanced methodologies to develop high-value products such as biodegradable polyhydroxyalkanoates (PHA), ectoine for pharmaceuticals, and cadaverine for nylon production. PhaBuilder is currently constructing two PHA production facilities, one in Beijing and another in Yichang, with plans to establish three to five large-scale production sites across China within five years. The company has successfully completed two rounds of financing, securing approximately 300 million yuan from notable investors. PhaBuilder aims to integrate synthetic biotechnology into various aspects of daily life and enhance the intelligent biological manufacturing sector, aspiring to fulfill its mission of utilizing microbes to foster a sustainable and eco-friendly future.
Vibrant
Venture Round in 2022
Vibrant develops an AI drug development platform to focus on building immune system-related drug pipelines. The company will use artificial intelligence algorithms to accelerate the efficiency of drug development in various aspects such as target discovery, drug design, and drug efficacy evaluation; at the same time, the company expects to continuously improve the success rate of drug development through sustainable data accumulation and algorithm optimization. It was founded and headed by Dr. Wang Luquan and is based in Guangzhou, Guangdong, China.
Parametrix.ai
Series B in 2022
Parametrix.ai is a startup focused on transforming the gaming industry through advanced artificial intelligence solutions. Founded in 2019 and headquartered in China, the company specializes in the integration of AI capabilities into game scenarios, enhancing the development process and player experience. Its technology encompasses machine learning, reinforcement learning, and large system engineering, enabling complex environmental sensing, decision-making, and the creation of dynamic game elements such as teams and enemies. By fostering AI entities as native participants in virtual worlds, Parametrix.ai aims to collaboratively design immersive and inclusive gaming environments that engage players in innovative ways.
Treelab
Series A in 2021
Treelab is a Shanghai-based company founded in 2019 that offers a productivity tool designed to enable non-technical users to create custom business systems. Its platform allows organizations to develop personalized software solutions for various functions, including project management, sales CRM, human resource management, and form collection. Treelab's SaaS-based platform simplifies the management of products, suppliers, orders, and invoices while providing real-time progress tracking and collaboration features. By streamlining the sourcing process and facilitating the design of unique workflows, Treelab empowers clients to efficiently manage their business operations without the need for programming expertise.
Recurrent.ai
Venture Round in 2021
Recurrent.ai is a Chinese company that specializes in AI-enabled corporate services aimed at enhancing sales efficiency. The company offers a comprehensive sales dialogue analysis system that converts voice interactions into text, facilitating in-depth analysis of sales calls and customer service conversations. By leveraging machine learning, Recurrent.ai helps businesses generate detailed big data dialogue analysis reports and maintain customer portrait records. These capabilities enable companies to optimize their sales processes, reduce labor costs, and improve sales conversion rates, ultimately supporting more informed decision-making.
Tungee
Series B in 2021
Tungee, established in 2016, is a provider of intelligent sales solutions for business-to-business enterprises. By utilizing big data and artificial intelligence technologies, including natural language processing and machine learning, Tungee offers a comprehensive platform that facilitates lead mining, business opportunity engagement, customer relationship management, and order analysis. This platform is designed to help enterprises efficiently identify, contact, and manage customers, thereby reducing customer acquisition costs and enhancing overall sales performance. Tungee has positioned itself as a leader in the Chinese intelligent sales sector, serving over 3,000 enterprise clients, including notable companies such as Alibaba and China Mobile. Through its innovative approach, Tungee addresses the challenges faced by businesses in sales forecasting and customer management.
QianDao App
Series B in 2021
QianDao App is a Shanghai-based company that specializes in developing trading software for blind box toys and garage kits, targeting youth in China. Founded in 2019, the platform allows users to customize and order toys according to their personal preferences. Its main offerings include the Happy Train and Wedding Flower Girl series, catering to a community of garage kit enthusiasts and collectors. By providing a space for interaction and trade among users, QianDao App fosters a vibrant culture around these collectible items.
Beijing Sudo Technology
Series A in 2021
Beijing Sudo Technology specializes in privacy protection services through comprehensive engineering solutions. The company has developed an encryption platform that enables secure data collaboration by utilizing advanced technologies such as cryptography, federated learning, and robust data engineering. This platform facilitates multi-party data collaboration while ensuring that original data remains untransmitted, allowing clients to work together securely and privately.
Neurophth Therapeutics
Series C in 2021
Wuhan Neurophth Biotechnology Co., Ltd. is a pioneering ophthalmology gene drug research and development company based in Wuhan, China, established in 2008. It focuses on gene therapies for ocular genetic diseases, with a particular emphasis on Leber hereditary optic neuropathy (LHON), a condition caused by genetic mutations. Neurophth has made significant advancements in the field, completing the world's first clinical study of gene therapy for LHON in 2011, which involved nine patients and has since observed their progress over seven years. The company aims to develop effective treatments for various ophthalmic disorders, including degenerative optic nerve injuries and vascular retinopathy, thereby providing physicians with innovative therapeutic options for patients suffering from these conditions.
ThinkingData
Series C in 2021
ThinkingData operates a big data analysis platform specifically designed for the gaming industry. The company utilizes advanced natural language processing and text mining technologies to provide users with real-time insights into player behavior, feedback, and public opinion on products. This comprehensive analysis aids gaming businesses in optimizing product experiences, enhancing operational efficiency, and driving user engagement and revenue growth. By offering a self-service data acquisition system, ThinkingData improves data awareness and analysis capabilities for its clients, enabling them to achieve greater data efficiency while reducing analytical costs.
Edge Medical Robotics
Series C in 2021
Edge Medical Robotics, Inc. is a company that specializes in designing and developing advanced surgical equipment. Founded on May 4, 2017, and based in Longgang, Shenzhen, China, the company is dedicated to researching and promoting cutting-edge medical technology. Its mission focuses on enhancing surgical safety and treatment efficacy, aiming to elevate the overall standards of healthcare. Through a commitment to excellence and precision in product development, Edge Medical Robotics strives to contribute positively to the improvement of social health outcomes.
Animoca Brands
Venture Round in 2021
Animoca Brands, established in 2019 and headquartered in the Cayman Islands, is a venture capital firm focused on the technology sector. It invests in and supports creators who leverage web3 and blockchain technologies to drive digital property rights to gamers and internet users through non-fungible tokens (NFTs). The company develops and markets a portfolio of mobile applications, games, and educational products, utilizing gamification and blockchain to ensure transparency, security, and innovative business models.
KAWO 科握
Seed Round in 2021
KAWO Technology LLC, founded in 2013 and based in Shanghai, specializes in providing social media solutions for international brands seeking to engage with Chinese audiences. The company develops an application that facilitates the creation and sharing of short-form videos and GIFs, specifically tailored for platforms such as Weibo and WeChat. KAWO's innovative tools enable brands to maintain authenticity and consistency across their social media channels while integrating Western platforms like Facebook and Twitter with their Chinese counterparts. By offering data insights and promoting transparency, KAWO enhances operational efficiency for global teams, allowing them to navigate the rapidly evolving Chinese social media landscape effectively.
Cellular Biomedicine Group
Series A in 2021
Cellular Biomedicine Group, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative immunotherapies for cancer and stem cell therapies for degenerative diseases in Greater China. The company employs proprietary cell-based technologies, including various forms of CAR-T therapy, which targets different cancer types, and human adipose-derived mesenchymal progenitor cells aimed at treating joint diseases. Its product pipeline features therapies such as CD20 and CD22 CAR-T for B cell malignancies, and alpha fetoprotein TCR-T targeting hepatocellular carcinoma. Additionally, Cellular Biomedicine is developing knee osteoarthritis treatments, including AlloJoin and Re-Join, the latter having completed Phase IIb trials. The company also engages in broader biopharmaceutical activities, encompassing research and development, technical support, and manufacturing of pharmaceutical polypeptides and medical devices. It has established a partnership with Novartis Pharma AG to produce and supply the CAR-T cell therapy Kymriah in China. Founded in 2001, Cellular Biomedicine Group is headquartered in New York, New York, and draws on a wealth of cellular medicine research and expertise from scientists and clinicians across the United States, England, and China.
Mech-Mind Robotics
Series C in 2021
Mech-Mind Robotics Technologies, founded in 2016 and based in Beijing, China, specializes in manufacturing smart cameras and developing AI-powered software for the logistics industry. The company produces a range of cameras, including the Mech-Eye Smart Camera, designed for tasks such as object recognition, depalletizing, assembly, sorting, and locating. Mech-Mind's technology integrates 3D vision with artificial intelligence, enabling robots to recognize objects of various shapes and sizes. With over 10,000 cameras deployed across more than 50 countries, Mech-Mind Robotics supports partners and system integrators in addressing complex automation challenges, including logistics parcel picking and related operations. The company also maintains an office in Munich, Germany, and a sales office in Shanghai, China.
XReal Technology
Series C in 2021
XReal Technology, founded in 2017 and based in Beijing, China, specializes in developing ready-to-wear mixed reality glasses. Their flagship product, Nreal Light, is designed to be lightweight and comfortable, featuring a vivid display and spatial computing algorithms for an immersive user experience. The company's goal is to make mixed reality technology widely accessible and to empower developers to create applications that enhance entertainment, productivity, and other areas. XReal Technology utilizes SLAM-based environment-understanding AI algorithms to provide users with an engaging mixed reality experience.
HAI ROBOTICS
Series D in 2021
HAI ROBOTICS, founded in 2016 and based in Shenzhen, China, specializes in autonomous case-handling robotic systems for warehouse automation. The company offers a variety of intelligent solutions, including a goods-to-person system, smart in-plant logistics solutions for manufacturing, and multi-tier steel platforms for diverse applications. As a pioneer in the field, HAI ROBOTICS launched its first autonomous case-handling robot, HAIPICK, in 2015, and has since focused on research and development, securing numerous patents. The HAIPICK system significantly enhances warehouse efficiency, reportedly increasing operational productivity by three to four times and boosting storage density by 80% to 130%. HAI ROBOTICS caters to a broad range of clients, including major logistics and supply chain companies, and is committed to delivering flexible and customizable automation solutions to optimize warehouse operations.
HAI ROBOTICS
Series C in 2021
HAI ROBOTICS, founded in 2016 and based in Shenzhen, China, specializes in autonomous case-handling robotic systems for warehouse automation. The company offers a variety of intelligent solutions, including a goods-to-person system, smart in-plant logistics solutions for manufacturing, and multi-tier steel platforms for diverse applications. As a pioneer in the field, HAI ROBOTICS launched its first autonomous case-handling robot, HAIPICK, in 2015, and has since focused on research and development, securing numerous patents. The HAIPICK system significantly enhances warehouse efficiency, reportedly increasing operational productivity by three to four times and boosting storage density by 80% to 130%. HAI ROBOTICS caters to a broad range of clients, including major logistics and supply chain companies, and is committed to delivering flexible and customizable automation solutions to optimize warehouse operations.
Syrius Robotics
Series B in 2021
Syrius Robotics, founded in 2018 and based in Shenzhen, China, specializes in manufacturing autonomous mobile robots for material handling in various sectors, including e-commerce, retail, and logistics. The company develops its own operational systems, software platforms, and AIoT cloud services to enhance the efficiency of fulfillment centers and warehouses worldwide. Utilizing advanced technologies such as Artificial Intelligence, laser radar, and camera systems, Syrius Robotics provides intelligent logistics solutions that improve productivity and streamline logistics management. Their products are increasingly adopted by a diverse range of commercial organizations beyond the transportation industry, showcasing the versatility of their automation solutions.
XtalPi Technology
Series D in 2021
XtalPi Inc. is a pharmaceutical technology company that focuses on digital drug development solutions, leveraging quantum mechanics and artificial intelligence to enhance the efficiency of drug research and development. Founded in 2014 by a group of quantum physicists at MIT, the company has developed its Intelligent Digital Drug Discovery and Development (ID4) platform, which integrates advanced cloud computing algorithms to aid pharmaceutical firms in critical stages of drug R&D. XtalPi offers various tools, including XtalForc for visual force field calculations, XtalVision for crystal structure predictions, and Renova for platform support of its AI research initiatives. Its comprehensive services encompass crystal structure determination, solid-state testing, small molecule drug design, and collaborations in antibody and peptide research. Based in Cambridge, Massachusetts, with additional offices in China, XtalPi has established strategic partnerships with leading international pharmaceutical companies, demonstrating the broad applicability and recognition of its innovative technologies across the pharmaceutical value chain.
Miaoshou Doctor
Series F in 2021
Miaoshou Doctor is a healthcare service platform established in 2015 by Tao He and Daoliang Han, headquartered in Beijing. The company focuses on facilitating communication between patients and healthcare professionals, enabling effective management of post-diagnosis outcomes. Its platform empowers doctors to actively monitor their patients' health through ongoing counseling and prescription support, enhancing the overall patient care experience. By streamlining interactions and follow-ups, Miaoshou Doctor aims to improve health outcomes and foster better relationships between patients and their healthcare providers.
Anovent Pharmaceutical
Venture Round in 2021
Shanghai Anovent Pharmaceutical Co., Ltd., founded in 2017 and headquartered in Shanghai, China, specializes in the development of high-quality inhalation medicines tailored for hospitals and medical institutions. The company focuses on offering safe and affordable pharmaceutical products, which include both generic and specialized inhalation therapies. By providing these medications, Anovent aims to enhance the quality of medical treatment available to patients in healthcare settings.
Bota Biosciences
Series B in 2021
Bota Biosciences is a global industrial biotechnology company based in Hangzhou, China, founded in 2019. The company specializes in synthetic bioengineering technology for bio-manufacturing, focusing on developing efficient, eco-friendly, and cost-effective solutions. Bota Biosciences has created an integrative bioengineering platform that connects biological design to scale-up manufacturing, facilitating the transition to sustainable living. It operates its own pilot plant and manufacturing facility, which enhances its capacity to offer scalable industrial solutions and market-ready products across various sectors, including nutrition, food, personal care, and animal health. With a dynamic and multidisciplinary team, Bota Biosciences aims to channel biotechnology innovations for a global impact. The company has successfully raised substantial funding, exceeding $145 million, with investments from several prominent strategic and financial backers.
Phabuilder
Angel Round in 2021
PhaBuilder is a technology company specializing in synthetic biology, particularly in the transformation and engineering of halophilic microbes. Founded in February 2021 by Professor Guoqiang Chen, the company employs advanced methodologies to develop high-value products such as biodegradable polyhydroxyalkanoates (PHA), ectoine for pharmaceuticals, and cadaverine for nylon production. PhaBuilder is currently constructing two PHA production facilities, one in Beijing and another in Yichang, with plans to establish three to five large-scale production sites across China within five years. The company has successfully completed two rounds of financing, securing approximately 300 million yuan from notable investors. PhaBuilder aims to integrate synthetic biotechnology into various aspects of daily life and enhance the intelligent biological manufacturing sector, aspiring to fulfill its mission of utilizing microbes to foster a sustainable and eco-friendly future.
Cloudwise
Series E in 2021
Founded in 2009, Cloudwise is a prominent provider of full-stack Artificial Intelligence for IT Operations (AIOps) solutions in China. The company focuses on optimizing IT operations, electric power IT operations, and Internet of Things (IoT) operations through its comprehensive platform, which encompasses IT Operations Management (ITOM), IT Operations Analytics (ITOA), IT Service Management (ITSM), DevOps, and IoT. Cloudwise has invested significantly in independent research and development, resulting in a robust industrial landscape. Headquartered in Beijing, the company operates three R&D centers in Beijing, Yanjiao, and Zhengzhou, along with three operational centers in Shanghai, Guangzhou, and Chengdu. Additionally, it has branches in Hong Kong, Singapore, Thailand, and Malaysia, providing extensive marketing services and technical support throughout China and Southeast Asia, thereby enhancing business operations and decision-making for its clients.
Westlake Therapeutics
Venture Round in 2021
Westlake Therapeutics is a biopharmaceutical company based in Hangzhou, China, founded in 2019. The company specializes in cell therapy, focusing on developing innovative treatments for rare diseases, cancer, and various immunological and metabolic disorders. Central to its approach is the REDx platform, which utilizes engineered red blood cell technology. This platform enables the genetic engineering of hematopoietic stem and progenitor cells sourced from peripheral blood, bone marrow, or cord blood. By leveraging this technology, Westlake Therapeutics aims to create personalized therapies that enhance treatment options for patients facing a wide range of health challenges.
HeyTea
Series D in 2021
HeyTea is a Chinese tea shop that focuses on innovative beverages, particularly cheese-topped tea and fruit tea. Founded in 2012 in an alley by the riverside, the company initially operated under the name ROYALTEA before rebranding to HEYTEA. The franchise offers a diverse range of products, including instant milk tea, fruit tea, and traditional Chinese tea, aimed at providing customers with unique flavor combinations. Through its distinct offerings, HeyTea has established itself as a prominent player in the tea beverage market.
dMed
Series C in 2021
dMed is a full-service Clinical Contract Research Organization that provides industry solutions to pharma and medical device companies. Its business covers consulting, regulatory affairs & strategy, early clinical development, clinical science & medical affairs, clinical operations, biostatistics & programming, data management, drug safety & pharmacovigilance, quality assurance, and information solutions. dMed has set up offices in major cities, including Shanghai, Beijing, Wuhan, New York, Washington, San Francisco, and Brussels, and it employs around 600 professionals globally, among them 60% holds master above degree and 25% with more than 10 years working experiences.
neoX Biotech
Venture Round in 2021
neoX BIOTECH is a biotechnology company established in 2018 and located in Beijing, China. The company specializes in the development of antigen-based cancer vaccines, leveraging a combination of artificial intelligence and biophysics to enhance drug research and development. neoX BIOTECH has created a neoantigen prediction and TCR screening platform that facilitates the discovery of effective macromolecular and multispecific drugs, particularly within the immuno-oncology sector. By characterizing protein-protein interactions, the company aims to advance early therapeutic discovery, ultimately improving treatment options for cancer patients.
AgileX
Venture Round in 2021
AgileX Robotics (Dongguan) Co., Ltd is a manufacturer based in Dongguan, China, with an additional office in Shenzhen. Founded in 2017, the company specializes in designing and producing mobile robot products, including unmanned ground vehicles (UGVs) and automated guided vehicles (AGVs). AgileX's offerings cater to various industries such as logistics, security, agriculture, and animal husbandry. The company aims to provide innovative solutions that enhance operational efficiency and reduce the manual workload through advanced robotics technology. Their products are utilized in applications such as security inspection, industrial park operations, agricultural irrigation, and scientific research, demonstrating a commitment to advancing intelligent robotics for broader workforce liberation.
Chehaoduo
Series E in 2021
Chehaoduo designs an online car trading platform that sells used cars. Its online car trading platform directly links individual car sellers and buyers, which help buyers remove the middlemen as well as purchase used cars easily. Haoyong Yang founded Chehaoduo in 2014, with its headquarters in Beijing in China, with branches in Chinese cities such as Hangzhou and Chongqing.
Micro Connect
Series A in 2021
Micro Connect is a financial market platform that specializes in connecting global capital with China's micro and small businesses. The company focuses on enhancing liquidity in small business investments by providing professional investors with a new alternative to traditional impact investing. Micro Connect introduces Daily Revenue Obligations (DROs), an innovative asset class that allows investors to gain direct and diversified exposure to the daily cash flows of numerous retail establishments within China's dynamic consumer market. By facilitating access to capital for business owners, Micro Connect aims to create a more affordable financial ecosystem, while also offering structured product solutions and operating a licensed exchange.
Mech-Mind Robotics
Series C in 2021
Mech-Mind Robotics Technologies, founded in 2016 and based in Beijing, China, specializes in manufacturing smart cameras and developing AI-powered software for the logistics industry. The company produces a range of cameras, including the Mech-Eye Smart Camera, designed for tasks such as object recognition, depalletizing, assembly, sorting, and locating. Mech-Mind's technology integrates 3D vision with artificial intelligence, enabling robots to recognize objects of various shapes and sizes. With over 10,000 cameras deployed across more than 50 countries, Mech-Mind Robotics supports partners and system integrators in addressing complex automation challenges, including logistics parcel picking and related operations. The company also maintains an office in Munich, Germany, and a sales office in Shanghai, China.
Beisen
Series F in 2021
Beijing Beisen Cloud Computing Co., Ltd. specializes in developing software as a service (SaaS) solutions for integrated talent management. Founded in 2005 and based in Beijing, the company offers a comprehensive platform that includes services for talent assessment, recruitment management, performance management, succession planning, and employee development. Beisen’s Human Resource Service Platform focuses on internet recruitment, while its Business People Service Network provides information and recruitment services. The company also delivers platform as a service (PaaS) for cloud architecture development, along with system implementation and custom development services. Its iTalentX platform features cloud-native applications designed to streamline human capital management (HCM) processes, enabling organizations to effectively recruit, evaluate, and retain talent throughout the employee lifecycle.
EdiGene
Series B in 2021
EdiGene Inc. is a biotechnology company based in Beijing, China, with additional offices in Guangzhou and Cambridge, Massachusetts. Founded in 2015, EdiGene specializes in the development of advanced genome editing technologies aimed at addressing various genetic diseases and cancer. The company focuses on both ex vivo and in vivo gene-editing therapies, utilizing proprietary platforms for modifying genetic information in human cells. Their innovative approaches include gene knockout, knock-in, and targeted mutations, which facilitate the creation of safer and more effective gene therapies. EdiGene also supports pharmaceutical research by providing high-throughput genome screening and drug target analysis, enhancing drug discovery efforts in the industry. Through its commitment to translating genome editing into therapeutics, EdiGene aims to improve human health outcomes and advance scientific research.
Connect Medical Value Technology
Series A in 2021
Connect Medical Value is a company based in Hangzhou, Zhejiang, China, that specializes in developing mobile applications for physicians. Founded in 2020, the company focuses on providing a comprehensive platform that integrates clinical services, scientific research, and educational resources. By leveraging advanced artificial intelligence technology, Connect Medical Value aims to enhance the capabilities of healthcare professionals, facilitating improved patient care and medical practice.
Qihan Biotech
Series A in 2021
Qihan Biotech is a biomedical company specializing in genetic technology with a focus on xenotransplantation. The company aims to address the critical shortage of organ donors by utilizing advanced gene editing techniques to develop safe and effective cells, tissues, and organs for human transplantation. Their mission is to eliminate the waiting period associated with organ transplants, providing patients with access to life-saving organs. By harnessing cutting-edge genetic editing technology, Qihan Biotech seeks to create viable organs that can be transplanted into humans, thereby contributing to a solution for the global organ donor crisis.
Neuracle
Series B in 2021
Neuracle is a prominent enterprise in China's neuroscience sector, specializing in neural monitoring and diagnostic technology. Leveraging advanced brain-machine interface technology developed in collaboration with Tsinghua University, Neuracle focuses on innovative research across neuroscience, psychology, and neuroengineering. The company provides comprehensive solutions for the diagnosis, treatment, and rehabilitation of clinical neurological diseases. Its product offerings include digital electroencephalographs that allow healthcare institutions to monitor patients' brain bioelectricity levels and facilitate accurate diagnoses of neural conditions. Neuracle's contributions span various fields, including clinical medicine and management marketing, and the company's research and development efforts have garnered recognition from experts in neuroscience and clinical medicine both domestically and internationally.
MetaX
Seed Round in 2021
Muxi is dedicated to providing full-stack GPU chips and heterogeneous computing solutions that can be widely used in cutting-edge fields such as artificial intelligence, smart cities, data centers, cloud computing, autonomous driving, digital twins, metaverse, and so on. It builds full-stack GPU chip products, launching MXN series GPUs (Xi Si) for AI reasoning, MXC series GPUs (Xi Yun) for AI training and general computing, and MXG series GPUs (Xi Cai) for graphics rendering, Meet the computing power requirements of data centers for "high energy efficiency" and "high versatility". Mu Xi's products all use independently developed GPU IP, have instruction sets and architectures with completely independent intellectual property rights, and are outfitted with a complete software stack (MACAMACA) compatible with mainstream GPU ecosystems. In September 2020, the company was founded in Shanghai, and it has wholly-owned subsidiaries and R&D centers in Beijing, Nanjing, Chengdu, Hangzhou, Shenzhen, and Wuhan.
Tim Hortons China
Venture Round in 2021
Tim Hortons China is a subsidiary of Tim Hortons Inc., established in 2018 and headquartered in Shanghai. The company operates a chain of coffee restaurants that serve a variety of coffee products alongside food offerings, including made-to-order shrimp sandwiches and salads. Tim Hortons China emphasizes customer service, addressing inquiries through multiple channels such as phone, email, and online applications. The company aims to provide a unique dining experience by blending coffee culture with fresh meal options in the Chinese market.
Moore Threads
Seed Round in 2021
Moore Threads, founded in 2020 and based in Beijing, China, specializes in developing Graphics Processing Unit (GPU) technology and services. The company focuses on enabling visual computing, artificial intelligence, and high-performance computing applications for a diverse range of sectors, including gaming and the creative industry. By providing advanced GPU technology and services for data centers, edge computing servers, professional workstations, and high-performance PCs, Moore Threads helps clients achieve significant computational power for their processes.
Furong Xingsheng
Venture Round in 2021
Furong Xingsheng, established in 2009 and headquartered in Changsha, China, operates convenience stores and offers B2B logistics and distribution services. The company's business model revolves around its community shopping platform, Xingsheng Youxuan, which was launched in 2018. This platform sources fresh products and caters to daily household consumer needs through an online ordering and offline pickup system, offering a wide range of fresh produce, groceries, and general merchandise.
Neurophth Therapeutics
Series B in 2021
Wuhan Neurophth Biotechnology Co., Ltd. is a pioneering ophthalmology gene drug research and development company based in Wuhan, China, established in 2008. It focuses on gene therapies for ocular genetic diseases, with a particular emphasis on Leber hereditary optic neuropathy (LHON), a condition caused by genetic mutations. Neurophth has made significant advancements in the field, completing the world's first clinical study of gene therapy for LHON in 2011, which involved nine patients and has since observed their progress over seven years. The company aims to develop effective treatments for various ophthalmic disorders, including degenerative optic nerve injuries and vascular retinopathy, thereby providing physicians with innovative therapeutic options for patients suffering from these conditions.
Babycare
Series B in 2021
Babycare is an e-commerce platform providing products for new parents and children. The company specializes in the design, research, and development of mother-baby products. Its products are based on recommendations by a series of research and experiments regarding orthopedic development of babies. One of its products is the infant waist carrier, which is crafted to improve the comfortability of infants and prevent from bowleg posturing which hinders blood circulation. The company is committed to achieving the aspiration of being product designers and baby caretakers. The company was founded in 2014 and is headquartered in Shanghai, China.
neoX Biotech
Series A in 2021
neoX BIOTECH is a biotechnology company established in 2018 and located in Beijing, China. The company specializes in the development of antigen-based cancer vaccines, leveraging a combination of artificial intelligence and biophysics to enhance drug research and development. neoX BIOTECH has created a neoantigen prediction and TCR screening platform that facilitates the discovery of effective macromolecular and multispecific drugs, particularly within the immuno-oncology sector. By characterizing protein-protein interactions, the company aims to advance early therapeutic discovery, ultimately improving treatment options for cancer patients.
WeShine Network
Series A in 2021
WeShine is a marketing and service platform that specializes in corporate account management solutions, primarily utilizing WeChat to enhance customer acquisition for businesses. Established in 2015 and headquartered in Nanjing, China, WeShine has successfully served over 150,000 businesses, with more than 30,000 of these being paid enterprise users. The platform focuses on integrated marketing and media services that leverage social media to enable mobile interaction and digital content sharing, helping clients to expand their customer base and improve marketing accuracy. With a global network of over 600 channel partners, WeShine operates offices in several major Chinese cities, including Guangzhou, Shenzhen, Beijing, Shanghai, Wuxi, and Wuhan.
Xiaobangguihua
Series B in 2021
XiaoBangGuiHua is an intelligent investment advisory service platform designed to assist Chinese middle-class families in managing their finances more effectively. The platform employs artificial intelligence algorithms and advanced asset allocation models to deliver systematic financial management solutions. It offers a variety of services, including personalized consultations and educational resources focused on financial risk management. Through its innovative approach, XiaoBangGuiHua aims to empower investors by providing them with the tools and knowledge necessary to enhance their financial decision-making and optimize their investment strategies.
4Paradigm
Series D in 2021
4Paradigm is a prominent artificial intelligence technology and service provider based in Beijing. The company specializes in enterprise AI, offering platform-centric software solutions that empower organizations to create their own decision-making AI applications. 4Paradigm's technology, particularly its innovative "migration learning" approach, is recognized as a significant advancement in AI, enabling enterprises to enhance efficiency, mitigate risks, and maximize commercial value. The company operates through three primary business segments: Sage AI Platform, SHIFT Intelligent Solutions, and SageGPT AIGS Services. These solutions are designed for large-scale deployment, allowing businesses to uncover hidden patterns in data and improve their decision-making processes. By focusing on enterprise needs rather than individual users, 4Paradigm positions itself as a leader in the AI sector, maintaining a competitive edge in migration learning technology.
Lalamove
Series F in 2021
Lalamove, originally known as EasyVan, was established in Hong Kong in December 2013 to address the demand for efficient van hire services. The company operates in 21 markets across Asia and Latin America, connecting over 7 million customers with a network of more than 700,000 driver-partners. Lalamove's on-demand logistics platform facilitates instant matching between customers and drivers, enabling same-day deliveries with an impressive average fulfillment time of just 55 minutes. The platform offers van-hailing and courier services, allowing customers to track their deliveries in real time and rate their drivers. By optimizing routes and fleets, Lalamove enhances the earning potential for drivers while providing reliable and swift delivery solutions for businesses and individuals alike.
NuProbe
Series B in 2021
NuProbe, Inc. is a genomics and molecular diagnostics company that focuses on noninvasive nucleic acid profiling and diagnostics. Founded in 2016 and headquartered in Cambridge, Massachusetts, with an additional office in Shanghai, China, NuProbe has developed a platform that utilizes genetic toehold probes for quantitative PCR mutation detection. The company's innovative technology offers a Sample-In Answer-Out (SIAO) solution, which seamlessly integrates cell-free DNA extraction, qPCR analysis, sequencing, and bioinformatic interpretation. This precision diagnostic technology is designed to facilitate the early detection of cancer and infectious diseases by accurately capturing disease signatures with high sensitivity and multiplexing capability, allowing healthcare professionals to initiate timely interventions for patients.
Visen Pharmaceuticals
Series B in 2021
Visen Pharmaceuticals is a biopharmaceutical company that specializes in the development and commercialization of innovative therapies for endocrine diseases. The company is dedicated to addressing significant unmet medical needs in this field, particularly within the Chinese market, and aims to provide both first-in-class and best-in-class treatment solutions for patients of all ages, including those with rare endocrine conditions. With a commitment to patient-centric care, Visen strives to improve treatment outcomes and quality of life for individuals affected by these diseases. The company is backed by a team of experienced professionals with extensive backgrounds in the pharmaceutical industry and operates offices in major Chinese cities such as Shanghai, Beijing, Hong Kong, and Taipei. To further enhance its research, development, and manufacturing capabilities, Visen has established a Greater China research and development site in Suzhou, aiming to deliver advanced treatment options to Chinese patients more effectively.
Hive Box Technology
Series C in 2021
Hive Box Technology, established in 2015 and headquartered in Shenzhen, China, specializes in operating a network of self-service package drop-off and pick-up stations. These stations, located in residential areas, are designed to facilitate 24/7 storage and retrieval of packages for express delivery companies and e-commerce logistics providers, enhancing convenience and efficiency in the supply chain.
STARLINK
Series B in 2021
STARLINK is an online technology company based in Shenzhen, China, with additional offices in Chengdu and Xuzhou. Founded in 2017, the company focuses on developing an e-commerce platform that leverages technology to streamline and integrate China's high-quality supply chain. STARLINK provides a variety of products for the overseas market, including apparel, footwear, and home and outdoor items. The company's goal is to connect global users with quality industrial products while enhancing the efficiency of the supply chain.
Insight Lifetech
Series C in 2020
Insight Lifetech is a medical technology company focused on creating innovative solutions for the diagnosis and treatment of cardiovascular diseases. It has developed a synergistic platform that integrates research and development, manufacturing, and commercialization, which enhances collaboration, accelerates product development, and promotes cost efficiency. The company is notable for creating the first and only domestic fractional flow reserve (FFR) system in China that has received approval from the National Medical Products Administration (NMPA). By manufacturing high-quality medical devices that feature reliable precision diagnostics and therapeutic capabilities, Insight Lifetech aims to empower physicians to improve patient outcomes and save lives.
Zuoyebang
Series E in 2020
Zuoyebang is an online education startup based in Beijing, China, founded in 2014 by Hou Jianbin. The company focuses on providing educational products and services for primary and high school students, utilizing artificial intelligence to enhance learning experiences. Its platform allows students to upload homework questions and seek answers, making it easier for them to tackle study-related challenges. In addition to homework assistance, Zuoyebang offers online courses, live lessons, and evaluations for students from kindergarten through 12th grade. The company has gained significant backing from prominent investors, including Baidu, Alibaba Group, Tiger Global Management, SoftBank Vision Fund, Sequoia Capital China, and FountainVest Partners.
Lalamove
Series E in 2020
Lalamove, originally known as EasyVan, was established in Hong Kong in December 2013 to address the demand for efficient van hire services. The company operates in 21 markets across Asia and Latin America, connecting over 7 million customers with a network of more than 700,000 driver-partners. Lalamove's on-demand logistics platform facilitates instant matching between customers and drivers, enabling same-day deliveries with an impressive average fulfillment time of just 55 minutes. The platform offers van-hailing and courier services, allowing customers to track their deliveries in real time and rate their drivers. By optimizing routes and fleets, Lalamove enhances the earning potential for drivers while providing reliable and swift delivery solutions for businesses and individuals alike.
Huolala
Series E in 2020
Huolala offers logistics services, moving, less-than-truckload, car rental and sales, and after-car services. Founded in 2013 and grown in the Guangdong-Hong Kong-Macao Greater Bay Area.
dMed
Series C in 2020
dMed is a full-service Clinical Contract Research Organization that provides industry solutions to pharma and medical device companies. Its business covers consulting, regulatory affairs & strategy, early clinical development, clinical science & medical affairs, clinical operations, biostatistics & programming, data management, drug safety & pharmacovigilance, quality assurance, and information solutions. dMed has set up offices in major cities, including Shanghai, Beijing, Wuhan, New York, Washington, San Francisco, and Brussels, and it employs around 600 professionals globally, among them 60% holds master above degree and 25% with more than 10 years working experiences.
CassTime
Series C in 2020
CassTime is an industrial internet company based in China that focuses on the automotive aftermarket. It operates a comprehensive trading platform that offers full coverage of spare parts, facilitating price inquiries and simplifying settlements for sellers of auto parts and accessories. In addition to its marketplace, CassTime provides a SaaS management system tailored for workshops, along with supply chain finance and logistics services. This integrated approach enables businesses to conduct transactions efficiently while accessing detailed information about vehicle parts, ultimately enhancing the overall experience for both buyers and sellers in the automotive sector.
SciNeuro
Series A in 2020
SciNeuro Pharmaceuticals is a biotechnology company based in Shanghai, China, focused on developing innovative medicines for patients with central nervous system (CNS) diseases. The company is committed to transforming the treatment landscape for these conditions through a robust product pipeline that emphasizes internal innovation and global collaboration. SciNeuro's drug development is guided by breakthrough scientific evidence, including insights from human genetics and pharmacology, targeting the underlying mechanisms of CNS diseases. By addressing these pathological mechanisms, SciNeuro aims to provide transformative therapies that not only aim to cure these diseases but also enhance the quality of life for patients.
Jiangxing Intelligence
Series A in 2020
Jiangxing Intelligence Inc., founded in 2018 by Professor Liu Jiangchuan, specializes in the development and operation of artificial intelligence (AI) and edge computing technologies tailored for the Internet of Things (IoT) in China. The company offers solutions such as EdgeBox, which enables real-time processing of big data for industrial clients across various sectors, including manufacturing, energy, transportation, and smart cities. Additionally, its Ubiquitous Wisdom Eye device provides intelligent monitoring for transmission lines by integrating data from various sensors, creating a cohesive supervision platform. Headquartered in Beijing, with offices in Shenzhen and Nanjing, Jiangxing Intelligence has secured significant venture capital funding, positioning itself as a leader in advanced edge computing applications for energy and industrial security.
Moore Threads
Seed Round in 2020
Moore Threads, founded in 2020 and based in Beijing, China, specializes in developing Graphics Processing Unit (GPU) technology and services. The company focuses on enabling visual computing, artificial intelligence, and high-performance computing applications for a diverse range of sectors, including gaming and the creative industry. By providing advanced GPU technology and services for data centers, edge computing servers, professional workstations, and high-performance PCs, Moore Threads helps clients achieve significant computational power for their processes.
Cloudwise
Series D in 2020
Founded in 2009, Cloudwise is a prominent provider of full-stack Artificial Intelligence for IT Operations (AIOps) solutions in China. The company focuses on optimizing IT operations, electric power IT operations, and Internet of Things (IoT) operations through its comprehensive platform, which encompasses IT Operations Management (ITOM), IT Operations Analytics (ITOA), IT Service Management (ITSM), DevOps, and IoT. Cloudwise has invested significantly in independent research and development, resulting in a robust industrial landscape. Headquartered in Beijing, the company operates three R&D centers in Beijing, Yanjiao, and Zhengzhou, along with three operational centers in Shanghai, Guangzhou, and Chengdu. Additionally, it has branches in Hong Kong, Singapore, Thailand, and Malaysia, providing extensive marketing services and technical support throughout China and Southeast Asia, thereby enhancing business operations and decision-making for its clients.
Zhiketong Technology
Series D in 2020
Beijing Zhiketong Technology Co., Ltd., established in 2014, specializes in providing direct marketing services for the hospitality, leisure, and entertainment sectors through its web platform on WeChat. The company acts as an agency that offers a range of digital marketing solutions, including consulting, advertising, and comprehensive data analysis. By assisting partners in optimizing their management efficiency and enhancing service quality, Zhiketong Technology helps businesses increase brand awareness and attract more customers. Its services encompass intelligent data analysis systems, online marketing strategies, customer management tools, and online store design, all aimed at driving revenue growth for hotels and tourism attractions in China.
VanTop Group
Series A in 2020
VanTop is an internet technology company headquartered in Shenzhen, dedicated to independent research and development while emphasizing product innovation. The company specializes in the development and retail of smart electronic devices, including projectors, tablets, drones, and smart home products. With a mission to "Explore the Beauty of Life," VanTop aims to establish itself as a leading consumer brand on a global scale. It operates subsidiaries in the United States, Hong Kong, Europe, and Japan, focusing on globalization, branding operations, and technological innovation to deliver high-quality products to consumers worldwide.
SmartSens Technology
Series B in 2020
SmartSens Technology is a company based in Shanghai that specializes in the research, development, design, and sales of high-performance CMOS image sensor chips. The company offers advanced imaging solutions applicable in various sectors, including surveillance, machine vision, automotive, and mobile cameras. With a commitment to innovation, SmartSens aims to enhance growth across multiple industries by providing a diverse and comprehensive portfolio of image sensors.
EdiGene
Series B in 2020
EdiGene Inc. is a biotechnology company based in Beijing, China, with additional offices in Guangzhou and Cambridge, Massachusetts. Founded in 2015, EdiGene specializes in the development of advanced genome editing technologies aimed at addressing various genetic diseases and cancer. The company focuses on both ex vivo and in vivo gene-editing therapies, utilizing proprietary platforms for modifying genetic information in human cells. Their innovative approaches include gene knockout, knock-in, and targeted mutations, which facilitate the creation of safer and more effective gene therapies. EdiGene also supports pharmaceutical research by providing high-throughput genome screening and drug target analysis, enhancing drug discovery efforts in the industry. Through its commitment to translating genome editing into therapeutics, EdiGene aims to improve human health outcomes and advance scientific research.
BambooCloud
Series C in 2020
Shenzhen BambooCloud Technology Co., Ltd. is a security management enterprise specializing in identity management and access control solutions. Headquartered in Shenzhen, China, with additional offices in major cities such as Beijing and Shanghai, BambooCloud has developed a comprehensive security platform that includes cloud application security management. The company offers consulting services, customized solutions, and SaaS products focused on enhancing enterprise information system security and management control for clients primarily in Europe, America, and ASEAN regions. Their proprietary identity management platform automates identity processes and provides multi-factor authentication for critical business transactions, ensuring effective control over user access privileges. This scalable solution supports both cloud and on-premise deployments, addressing compliance requirements while improving cyber resilience and user convenience.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.